AMKOR TECHNOLOGY, INC. (AMKR) FY2024 Q2 Balance Sheet
As of 2024-06-30
Balance Sheet
As of 2024-06-30
Swipe to see the full flow
Chart details
AMKOR TECHNOLOGY, INC. (AMKR) FY2024 Q2 Balance Sheet
Balance sheet as of 2024-06-30. The chart shows assets, liabilities and equity at that date.
- Assets
- 6,865,550,000 US dollars
- Current assets
- 3,136,841,000 US dollars
- Non-current assets
- 3,728,709,000 US dollars
- Liabilities
- 2,782,216,000 US dollars
- Current liabilities
- 1,506,600,000 US dollars
- Non-current liabilities
- 1,275,616,000 US dollars
- Equity
- 4,083,334,000 US dollars
- Noncontrolling interest
- 33,677,000 US dollars. Included in consolidated equity; this amount is not added again.
- Accounts receivable, net of allowances
- 1,147,940,000 US dollars
- Cash and cash equivalents
- 1,079,663,000 US dollars
- Short-term investments (amortized cost of $466,128 and $474,663 in 2024 and 2023, respectively)
- 465,804,000 US dollars
- Inventories
- 379,259,000 US dollars
- Other current assets
- 64,175,000 US dollars
- Property, plant and equipment, net
- 3,480,996,000 US dollars
- Other assets
- 123,888,000 US dollars
- Operating lease right of use assets
- 105,527,000 US dollars
- Goodwill
- 17,536,000 US dollars
- Restricted cash
- 762,000 US dollars
- Trade accounts payable
- 734,755,000 US dollars
- Accrued expenses
- 318,753,000 US dollars
- Capital expenditures payable
- 274,702,000 US dollars
- Short-term borrowings and current portion of long-term debt
- 154,403,000 US dollars
- Short-term operating lease liability
- 23,987,000 US dollars
- Long-term debt
- 949,320,000 US dollars
- Other non-current liabilities
- 193,323,000 US dollars
- Pension and severance obligations
- 78,423,000 US dollars
- Long-term operating lease liabilities
- 54,550,000 US dollars
- Retained earnings
- 2,246,795,000 US dollars
- Additional paid-in capital
- 2,022,512,000 US dollars
- Accumulated other comprehensive income (loss)
- 4,214,000 US dollars
- Common stock, $0.001 par value, 500,000 shares authorized; 292,642 and 292,167 shares issued; and 246,302 and 245,888 shares outstanding in 2024 and 2023, respectively
- 293,000 US dollars
- Preferred stock, $0.001 par value, 10,000 shares authorized, designated Series A, none issued
- 0 US dollars
- Non-controlling interests in subsidiaries
- 33,677,000 US dollars
- Treasury stock, at cost, 46,340 and 46,279 shares in 2.024 and 2023, respectively
- negative 224,157,000 US dollars
- Gross equity (calculated)
- 4,307,491,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
